Allspring Global Investments
ALNY icon

Allspring Global Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Allspring Global Investments’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768K Sell
2,546
-279,247
-99% -$84.2M ﹤0.01% 1318
2026
Q1 		$92.6M Buy
281,793
+3,136
+1% +$1.07M 0.16% 155
2025
Q4 		$112M Sell
278,657
-32,147
-10% -$14.2M 0.18% 139
2025
Q3 		$143M Sell
310,804
-1,412
-0.5% -$575K 0.23% 114
2025
Q2 		$101M Buy
312,216
+41,292
+15% +$11.4M 0.17% 147
2025
Q1 		$69.3M Buy
+270,924
New +$69.6M 0.12% 208
2024
Q4 		– Sell
-420
Closed -$116K – 1773
2024
Q3 		$116K Buy
420
+161
+62% +$41.9K ﹤0.01% 1763
2024
Q2 		$62.9K Buy
259
+91
+54% +$14.4K ﹤0.01% 1932
2024
Q1 		$25.1K Buy
168
+143
+572% +$23.9K ﹤0.01% 2064
2023
Q4 		$4.79K Sell
25
-77,988
-100% -$13.3M ﹤0.01% 2059
2023
Q3 		$13.8M Buy
78,013
+50,124
+180% +$9.56M 0.02% 648
2023
Q2 		$5.3M Sell
27,889
-6,492
-19% -$1.29M 0.01% 978
2023
Q1 		$6.89M Sell
34,381
-2,887
-8% -$607K 0.01% 903
2022
Q4 		$8.86M Sell
37,268
-246
-0.7% -$52.5K 0.02% 812
2022
Q3 		$7.51M Sell
37,514
-1,603
-4% -$306K 0.01% 865
2022
Q2 		$5.7M Sell
39,117
-851
-2% -$121K 0.01% 952
2022
Q1 		$6.53M Buy
39,968
+14,121
+55% +$2.15M 0.01% 1036
2021
Q4 		$4.38M Buy
+25,847
New +$4.8M ﹤0.01% 1225

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's ALNY Position: Q2 2026 in Review

Allspring Global Investments reduced its Alnylam Pharmaceuticals (ALNY) stake by 99% in Q2 2026, selling an estimated $84.2M and leaving 2,546 shares worth $768K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

Allspring Global Investments first reported a position in ALNY in Q4 2021 and has held it in 18 quarters since. The position peaked at $143M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Allspring Global Investments held 2,546 shares of Alnylam Pharmaceuticals worth $768K as of Q2 2026.
  • Allspring Global Investments sold 279,247 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $84.2M.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1318 holding.
  • Allspring Global Investments first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Alnylam Pharmaceuticals position peaked at $143M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.